相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A systematic review of St. John's wort for major depressive disorder
Eric A. Apaydin et al.
SYSTEMATIC REVIEWS (2016)
Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone
Tore Bjerregaard Stage et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Effect of Induction of CYP3A4 by St John's Wort on Ambrisentan Plasma Pharmacokinetics in Volunteers of known CYP2C19 Genotype
Christoph Markert et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety
Y. -R. Liu et al.
CLIMACTERIC (2014)
The Effect of St John's Wort on the Pharmacokinetics of Docetaxel
Andrew K. L. Goey et al.
CLINICAL PHARMACOKINETICS (2014)
Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentan
Christoph Markert et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers
Akil Jackson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study
Syed Ziaur Rahman et al.
AUSTRALASIAN PSYCHIATRY (2013)
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression
Daniela Solomon et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
St John's wort greatly decreases the plasma concentrations of oral S-ketamine
Marko A. Peltoniemi et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review
Elena Laakmann et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Interaction of St John's wort (Hypericum perforatum) with clozapine
Annelies C. P. Van Strater et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance
Bill J. Gurley et al.
PLANTA MEDICA (2012)
The Pregnane X Receptor Agonist St John's Wort Has No Effects on the Pharmacokinetics and Pharmacodynamics of Repaglinide
Lan Fan et al.
CLINICAL PHARMACOKINETICS (2011)
The quality of information on websites selling St. John's wort
Vijeta Thakor et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2011)
Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes
Juho Hokkanen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The Effect of St John's Wort on the Pharmacodynamic Response of Clopidogrel in Hyporesponsive Volunteers and Patients: Increased Platelet Inhibition by Enhancement of CYP3A4 Metabolic Activity
Wei C. Lau et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Drug interaction between St John's wort and zolpidem in healthy subjects
Y. Hojo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Drug interactions with St. John's wort products
Julia Vlachojannis et al.
PHARMACOLOGICAL RESEARCH (2011)
St John's wort greatly reduces the concentrations of oral oxycodone
Tuija H. Nieminen et al.
EUROPEAN JOURNAL OF PAIN (2010)
St. John's Wort Constituents Modulate P-glycoprotein Transport Activity at the Blood-Brain Barrier
Melanie Ott et al.
PHARMACEUTICAL RESEARCH (2010)
Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers
H. -P. Lei et al.
XENOBIOTICA (2010)
Herb-Drug Interactions with St John's Wort (Hypericum perforatum): an Update on Clinical Observations
Francesca Borrelli et al.
AAPS JOURNAL (2009)
Reduced Efficacy of Rosuvastatin by St. John's Wort
Ram Y. Gordon et al.
AMERICAN JOURNAL OF MEDICINE (2009)
St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive
Liane Will-Shahab et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers
Silke C. Mueller et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men
Anna Lundahl et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide
H. Xu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Molecular Mechanisms Underlying St. John's Wort Drug Interactions
Maike Kober et al.
CURRENT DRUG METABOLISM (2008)
Clinical assessment of CYP2D6-mediated herb-drug interactions in humans:: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea
Bill J. Gurley et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: Comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxiin pharmacokinetics
Bill J. Gurley et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Lack of pharmacokinetic interaction between St. John's Wort and prednisone
Edward C. Bell et al.
ANNALS OF PHARMACOTHERAPY (2007)
Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia
L. Andren et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort
Ute Goedtel-Armbrust et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol
U. I. Schwarz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effects of St. John's Wort supplementation on ibuprofen pharmacokinetics
Edward C. Bell et al.
ANNALS OF PHARMACOTHERAPY (2007)
Effects of treatment with a commercially available St John's Wort product (Movina (R)) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin
Robert Eggertsen et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2007)
Hyperforin and its analogues inhibit CYP3A4 enzyme activity
Ju-young Lee et al.
PHYTOCHEMISTRY (2006)
Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers:: An open-label, pharmacokinetic interaction clinical trial
A. Portoles et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Hypericum perforatum:: Which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
Heike Gutmann et al.
PLANTA MEDICA (2006)
Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement
JJ Gagnier et al.
ANNALS OF INTERNAL MEDICINE (2006)
Hyperforin in St. John's wort drug interactions
R Madabushi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort
A Chaudhary et al.
TOXICOLOGY (2006)
Quality of reporting of randomized controlled trials of herbal medicine interventions
Joel J. Gagnier et al.
AMERICAN JOURNAL OF MEDICINE (2006)
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose
SC Mueller et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways
S Krusekopf et al.
PHARMACOGENETICS AND GENOMICS (2005)
Effects of st John's Wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women:: A pilot study
JL Donovan et al.
PHYTOTHERAPY RESEARCH (2005)
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics
J Rengelshausen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding
PA Murphy et al.
CONTRACEPTION (2005)
No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract
G Arold et al.
PLANTA MEDICA (2005)
CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations
RJ Xie et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly - St John's wort, garlic oil, Panax ginseng and Ginkgo biloba
BJ Gurley et al.
DRUGS & AGING (2005)
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
XM Jiang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females
M Wenk et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism
C Tannergren et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole
LS Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Drug interaction between St John's Wort and quazepam
A Kawaguchi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effect of St John's wort on imatinib mesylate pharmacokinetics
RF Frye et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Interaction of St John's wort with conventional drugs: systematic review of clinical trials
E Mills et al.
BRITISH MEDICAL JOURNAL (2004)
Effect of St. John's Wort on the pharmacokinetics of theophylline in healthy volunteers
T Morimoto et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The influence of St. John's Wort on the pharmacokinetics and protein binding of imatinib mesylate
P Smith
PHARMACOTHERAPY (2004)
The influence of St. John's wort on CYP2C19 activity with respect to genotype
LS Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin
SC Mueller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction
I Mai et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The interaction between St John's wort and an oral contraceptive
SD Hall et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme
JS Markowitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients
S Bauer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial
A Pfrunder et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Coordinate induction of both cytochrome P4503A and MDRI by St John's wort in healthy subjects
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans
BJ Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Effect of St John's wort on the pharmacokinetics of fexofenadine
ZQ Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's Wort (Hypericum perforatum)
A Johne et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin
K Sugimoto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Efficacy and tolerability of Ze 117 St. John's wort extract in comparison with placebo, imipramine and fluoxetine for the treatment of mild to moderate depression according to ICD-10.: An overview
R Käufeler et al.
PHARMACOPSYCHIATRY (2001)
St John's wort (Hypericum perforatum L.):: a review of its chemistry, pharmacology and clinical properties
J Barnes et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Drug interaction between St John's wort and nevirapine
MMR de Maat et al.
AIDS (2001)
Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers
AH Burstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
D Dürr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
St John's Wort: Effect on CYP3A4 activity
CA Roby et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Indinavir concentrations and St John's wort
SC Piscitelli et al.
LANCET (2000)
Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers
JS Markowitz et al.
LIFE SCIENCES (2000)
分享论文
